Your browser doesn't support javascript.
loading
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.
Kellner, Christian; Lutz, Sebastian; Oberg, Hans-Heinrich; Wesch, Daniela; Otte, Anna; Diemer, Katarina J; Wilcken, Hauke; Bauerschlag, Dirk; Glüer, Claus-Christian; Wichmann, Christian; Kabelitz, Dieter; Leusen, Jeanette H W; Klausz, Katja; Humpe, Andreas; Gramatzki, Martin; Peipp, Matthias.
Afiliação
  • Kellner C; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Max-Lebsche-Platz 32, D-81377 Munich, Germany.
  • Lutz S; Department of Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University of Kiel, D-24105 Kiel, Germany.
  • Oberg HH; Institute of Immunology, Christian-Albrechts-University of Kiel and University Hospital Schleswig-Holstein, D-24105 Kiel, Germany.
  • Wesch D; Institute of Immunology, Christian-Albrechts-University of Kiel and University Hospital Schleswig-Holstein, D-24105 Kiel, Germany.
  • Otte A; Department of Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University of Kiel, D-24105 Kiel, Germany.
  • Diemer KJ; Department of Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University of Kiel, D-24105 Kiel, Germany.
  • Wilcken H; Department of Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University of Kiel, D-24105 Kiel, Germany.
  • Bauerschlag D; Department of Gynecology and Obestrics, University Medical Centre Schleswig-Holstein, Campus Kiel, D-24105 Kiel, Germany.
  • Glüer CC; Department of Radiology and Neurology, Section Biomedical Imaging, University Hospital Schleswig-Holstein, D-24118 Kiel, Germany.
  • Wichmann C; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Max-Lebsche-Platz 32, D-81377 Munich, Germany.
  • Kabelitz D; Institute of Immunology, Christian-Albrechts-University of Kiel and University Hospital Schleswig-Holstein, D-24105 Kiel, Germany.
  • Leusen JHW; Laboratory of Translational Immunology, University Medical Center, NL-3584 Utrecht, Netherlands.
  • Klausz K; Department of Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University of Kiel, D-24105 Kiel, Germany.
  • Humpe A; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Max-Lebsche-Platz 32, D-81377 Munich, Germany.
  • Gramatzki M; Department of Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University of Kiel, D-24105 Kiel, Germany.
  • Peipp M; Department of Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University of Kiel, D-24105 Kiel, Germany.
Biol Chem ; 403(5-6): 545-556, 2022 04 26.
Article em En | MEDLINE | ID: mdl-34717050
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Subfamília K de Receptores Semelhantes a Lectina de Células NK Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Subfamília K de Receptores Semelhantes a Lectina de Células NK Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article